
Tested Applications
Positive WB detected in | A549 cells, HepG2 cells,MCF-7 cells,HeLa cells,HEK-293 cells,NIH/3T3 cells,C6 cells |
Positive IP detected in | HeLa cells |
Positive IHC detected in | human ovary tumor tissue, human cervical cancer tissue,human breast cancer tissueNote: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF detected in | HeLa cells |
Positive FC detected in | HeLa cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:8000 |
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB |
Immunohistochemistry (IHC) | IHC : 1:200-1:1000 |
Immunofluorescence (IF) | IF : 1:50-1:500 |
Sample-dependent, check data in validation data gallery |
Published Applications
KD/KO | See 6 publications below |
WB | See 346 publications below |
IHC | See 9 publications below |
IF | See 1 publications below |
IP | See 1 publications below |
Product Information
10176-2-AP targets AKT inWB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | A. sphaerocephala Krasch, blunt snout bream, carp, chicken, cow, fish, hamster, human, mouse, rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | AKT fusion protein Ag0213 |
Full Name | v-akt murine thymoma viral oncogene homolog 1 |
Calculated molecular weight | 56 kDa |
Observed molecular weight | 56-62 kDa |
GenBank accession number | BC000479 |
Gene symbol | AKT1 |
Gene ID (NCBI) | 207 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for-20oC storage. |
Background Information
The serine-threonine protein kinase AKT1 is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for AKT antibody 10176-2-AP | Download protocol |
IHC protocol for AKT antibody 10176-2-AP | Download protocol |
IF protocol for AKT antibody 10176-2-AP | Download protocol |
IP protocol for AKT antibody 10176-2-AP | Download protocol |
FC protocol for AKT antibody 10176-2-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
ebiomall.com







